Photo of Katia Georgopoulos,  PhD

Katia Georgopoulos, PhD

Massachusetts General Hospital

Massachusetts General Hospital
Phone: (617) 726-4445
Fax: (617) 726-4453


katia.georgopoulos@cbrc2.mgh.harvard.edu

Katia Georgopoulos, PhD

Massachusetts General Hospital

EDUCATIONAL TITLES

  • Professor, Dermatology, Harvard Medical School
  • Associate Biologist, Dermatology, Massachusetts General Hospital

DF/HCC PROGRAM AFFILIATION

Research Abstract

The successful transition of hemopoietic progenitors through the process of lineage commitment and differentiation relies on the precise orchestration of events in gene activation and repression. Our earlier studies on this developmental system have identified the Ikaros family of DNA binding factors. We have shown that these proteins impact the early commitment steps into the hemopoietic and lymphoid lineages and are critical regulators of proliferation in mature T and B cell lymphocytes. We are currently focused on the molecular mechanisms by which these factors effect their function in differentiation. We have recently shown that Ikaros and family members form distinct chromatin remodeling complexes in lymphocytes. The focus of our future research is to delineate the role and regulation of these remodeling complexes in the process of lineage determination and proliferation by a series of biochemical and genetic approaches.

Publications

Powered by Harvard Catalyst
  • Georgopoulos K. Ebf1 in DNA repair and leukemogenesis. Blood 2015; 125:3969-71. PubMed
  • Perotti EA, Georgopoulos K, Yoshida T. An Ikaros Promoter Element with Dual Epigenetic and Transcriptional Activities. PLoS ONE 2015; 10:e0131568. PubMed
  • Yoshida T, Georgopoulos K. Ikaros fingers on lymphocyte differentiation. Int J Hematol 2014; 100:220-9. PubMed
  • Yamada T, Yang Y, Hemberg M, Yoshida T, Cho HY, Murphy JP, Fioravante D, Regehr WG, Gygi SP, Georgopoulos K, Bonni A. Promoter decommissioning by the NuRD chromatin remodeling complex triggers synaptic connectivity in the mammalian brain. Neuron 2014; 83:122-34. PubMed
  • Joshi I, Yoshida T, Jena N, Qi X, Zhang J, Van Etten RA, Georgopoulos K. Loss of Ikaros DNA-binding function confers integrin-dependent survival on pre-B cells and progression to acute lymphoblastic leukemia. Nat Immunol 2014; 15:294-304. PubMed
  • Dose M, Emmanuel AO, Chaumeil J, Zhang J, Sun T, Germar K, Aghajani K, Davis EM, Keerthivasan S, Bredemeyer AL, Sleckman BP, Rosen ST, Skok JA, Le Beau MM, Georgopoulos K, Gounari F. β-Catenin induces T-cell transformation by promoting genomic instability. Proc Natl Acad Sci U S A 2014; 111:391-6. PubMed
  • Yoshida T, Landhuis E, Dose M, Hazan I, Zhang J, Naito T, Jackson AF, Wu J, Perotti EA, Kaufmann C, Gounari F, Morgan BA, Georgopoulos K. Transcriptional regulation of the Ikzf1 locus. Blood 2013; 122:3149-59. PubMed
  • Yoshida T, Georgopoulos K. GATA-3 controls self-renewal in stressed HSCs. Nat Immunol 2013; 14:1032-3. PubMed
  • Quintana FJ, Jin H, Burns EJ, Nadeau M, Yeste A, Kumar D, Rangachari M, Zhu C, Xiao S, Seavitt J, Georgopoulos K, Kuchroo VK. Aiolos promotes TH17 differentiation by directly silencing Il2 expression. Nat Immunol 2012; 13:770-7. PubMed
  • Gómez-del Arco P, Kashiwagi M, Jackson AF, Naito T, Zhang J, Liu F, Kee B, Vooijs M, Radtke F, Redondo JM, Georgopoulos K. Alternative promoter usage at the Notch1 locus supports ligand-independent signaling in T cell development and leukemogenesis. Immunity 2010; 33:685-98. PubMed
  • Yoshida T, Ng SY, Georgopoulos K. Awakening lineage potential by Ikaros-mediated transcriptional priming. Curr Opin Immunol 2010; 22:154-60. PubMed
  • Martín-Ibáñez R, Crespo E, Urbán N, Sergent-Tanguy S, Herranz C, Jaumot M, Valiente M, Long JE, Pineda JR, Andreu C, Rubenstein JL, Marín O, Georgopoulos K, Mengod G, Fariñas I, Bachs O, Alberch J, Canals JM. Ikaros-1 couples cell cycle arrest of late striatal precursors with neurogenesis of enkephalinergic neurons. J Comp Neurol 2009; 518:329-51. PubMed
  • Mandal M, Powers SE, Ochiai K, Georgopoulos K, Kee BL, Singh H, Clark MR. Ras orchestrates exit from the cell cycle and light-chain recombination during early B cell development. Nat Immunol 2009; 10:1110-7. PubMed
  • Ng SY,Yoshida T,Zhang J,Georgopoulos K. Genome-wide lineage-specific transcriptional networks underscore Ikaros-dependent lymphoid priming in hematopoietic stem cells. Immunity 2009; 30:493-507. PubMed
  • Georgopoulos K. Acute lymphoblastic leukemia--on the wings of IKAROS. N Engl J Med 2009; 360:524-6. PubMed
  • Georgopoulos K. From immunity to tolerance through HDAC. Nat Immunol 2008; 10:13-4. PubMed
  • Naito T, Gomez-Del Arco P, Williams CJ, Georgopoulos K. Antagonistic interactions between Ikaros and the chromatin remodeler Mi-2beta determine silencer activity and Cd4 gene expression. Immunity 2007; 27:723-34. PubMed
  • Agoston DV, Szemes M, Dobi A, Palkovits M, Georgopoulos K, Gyorgy A, Ring MA. Ikaros is expressed in developing striatal neurons and involved in enkephalinergic differentiation. J Neurochem 2007; 102:1805-16. PubMed
  • Kioussis D, Georgopoulos K. Epigenetic flexibility underlying lineage choices in the adaptive immune system. Science 2007; 317:620-2. PubMed
  • Ng SY, Yoshida T, Georgopoulos K. Ikaros and chromatin regulation in early hematopoiesis. Curr Opin Immunol 2007; 19:116-22. PubMed
  • Kashiwagi M, Morgan BA, Georgopoulos K. The chromatin remodeler Mi-2beta is required for establishment of the basal epidermis and normal differentiation of its progeny. Development 2007; 134:1571-82. PubMed
  • Thompson EC, Cobb BS, Sabbattini P, Meixlsperger S, Parelho V, Liberg D, Taylor B, Dillon N, Georgopoulos K, Jumaa H, Smale ST, Fisher AG, Merkenschlager M. Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits. Immunity 2007; 26:335-44. PubMed
  • Yoshida T, Ng SY, Zuniga-Pflucker JC, Georgopoulos K. Early hematopoietic lineage restrictions directed by Ikaros. Nat Immunol 2006; 7:382-91. PubMed
  • Ueda Y, Okano M, Williams C, Chen T, Georgopoulos K, Li E. Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome. Development 2006; 133:1183-92. PubMed
Hide